MedPath

Beating the Blues.

Suspended
Conditions
(Sub)clinical depression, anxiety symptoms
Registration Number
NL-OMON22545
Lead Sponsor
InterhealthGrotekerksplein 43311 CC DordrechtT: 0880104300www.interhealth.nl
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
374
Inclusion Criteria

All clients of Mentaal Beter in the age range of 18 to 65 with a score between 14 and 28 on the BDI-II-NL (Van der Does, 2002) will be asked to participate in the study. The minimal duration of the depressive complaints needs to be at least two months. The participants also need to be native Dutch speakers and to have access to internet and e-mail at home.

Exclusion Criteria

These participants will only be asked to participate in the study when they receive no other psychological treatment for their depressive complaints. Furthermore, the presence of suicide ideation, severe co-morbid diagnoses (in particular current psychosis and organic mental disorders) and substance abuse are not allowed.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameter is the presence/ severity of depressive symptoms as measured with the Beck Depression Inventory (BDI-II-NL). Other clinical and economic questionnaires (CORE-34, PHQ-9, BADS, DAS, WSAS, EQ-5D/VAS, TiC-P) will be used to back up the main study parameter. More specifically, they will be used to answer the research questions about (cost) effectiveness.
Secondary Outcome Measures
NameTimeMethod
The secondary study parameters are:<br /><br>1. Client acceptability ratings, as measured with the AQ (long and short versions);<br /><br>2. Presence/ severity of anxiety symptoms, as measured with the anxiety subscale of the CORE-34 and with the GAD-7. <br><br /><br /><br>Age, sex, social economic status and ethnical background will be used as prognostic factors.
© Copyright 2025. All Rights Reserved by MedPath